GlaxoSmithKline PLC Director/PDMR Shareholding (7803D)
21 Febbraio 2020 - 2:00PM
UK Regulatory
TIDMGSK
RNS Number : 7803D
GlaxoSmithKline PLC
21 February 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Ms V Whyte
==== ====================================== ==================================================
b) Position/status Company Secretary
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Transfer of 10,720 Ordinary Shares between
transaction accounts for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 10,720
=================================================================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2020-02-20
==== ====================================== ==================================================
f) Place of the transaction N/A
====================================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Ms V Whyte
==== ====================================== ==================================================
b) Position/status Company Secretary
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Transfer of 10,838 Ordinary Shares to
transaction spouse for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 10,838
=================================================================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2020-02-20
==== ====================================== ==================================================
f) Place of the transaction N/A
====================================== ==================================================
Details of PDMR/person closely associated with them
('PCA')
==========================================================================================
a) Name Mr I Whyte
==== ====================================== ==================================================
b) Position/status PCA of Ms V Whyte (Company Secretary)
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Receipt of 10,838 Ordinary Shares from
transaction spouse for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 10,838
=================================================================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2020-02-20
==== ====================================== ==================================================
f) Place of the transaction N/A
====================================== ==================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLFLFLBLLEBBK
(END) Dow Jones Newswires
February 21, 2020 08:00 ET (13:00 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024
